• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Difficult to Open or Close (2921)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 09/08/2021
Event Type  Injury  
Event Description
On (b)(6) 2021, a perceval valve pvs23 implant attempt occurred.After the implant the leaflets appeared stiff.The valve was explanted and replaced with a perimount valve size 21.Based on additional information provided, the valve collapsing and preparation was performed as usual, no anomalies were detected.The valve positioning in the dual collapser occurred with no problem and the valve was collapsed normally.The valve was stored in saline solution prior to the implant.After the valve implant and declamp, the echo showed that the valve leaflets were "frozen" (i.E.Blocked in the open position).The valve was not closing and the echo findings showed a massive aortic insufficiency.The valve appeared well positioned.The bypass was restarted and the valve inspected.The leaflets appeared not to close properly and were immobile.No cusp tears were identified, but the leaflets appeared thickened.There was no adverse event for the patient who was already discharged after finally implanting perimount valve 21 instead.
 
Manufacturer Narrative
The device returned to the manufacturer for investigation.The returned prosthesis was received in a bad state of conservation.On the 1st and 3rd leaflets there are 2 spots (they look like mold).The height of each package leaflet was checked using the specific tool and it resulted in compliance.The dimensional check carried out did not reveal any anomalies.The visual inspection did not highlight any pre-existing defects.The valve in question therefore complies with the required specifications.Considering the bad state of conservation of the returned prosthesis, it was not possible to perform any further analysis on the returned prosthesis.The manufacturing and material records for the perceval heart valve, model #icv1209, s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.This review included the steady flow test inspection performed at the time of manufacture and release of the prosthesis in question.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.The steady flow test review demonstrate the acceptable opened and closed leaflet performance of the perceval pvs23 sn# (b)(6).No anomalies are observed during the open/close cycle.The valve therefore meets the acceptance criteria of the steady flow test inspection as defined in the principal device function test at the time of release.Based on the investigations performed, no product malfunction was identified in the returned prosthesis.Although the prosthesis was received in a bad conservation state, no elements of non conformities were identified in the prosthesis, which resulted in compliance with the manufacturer's specifications for a model icv1209/pvs23.Furthermore, the review of the steady flow test performed at the time of manufacture and release of the valve confirmed a good leaflets functionality.Ultimately, considering the results of the investigation and the available information, a definitive root cause for the reported event cannot be established at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key12595485
MDR Text Key278761678
Report Number3004478276-2021-00265
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)240403
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/07/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/03/2024
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/18/2021
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/18/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/03/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-